Safety test of an experimental VEE vaccine in healthy adults
Part of Brain & nervous system, Infections clinical trials.
This study tests a new vaccine, V4020, that may help protect against Venezuelan equine encephalitis (VEE), a rare but serious virus spread by mosquitoes. It is the first step in humans to see if it is safe and how the body responds.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 to 50 years old.
- You must not have had this vaccine or the virus before.
- You must be generally healthy with no major medical conditions.
- If you can become pregnant, you must agree to use effective birth control for 3 months after vaccination.
- You must be willing to follow the study schedule, keep a symptom diary, and report any side effects.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a booster dose of an existing vaccine against Venezuelan equine encephalitis (VEE) virus, which can cause brain infection. The goal is to see if the booster safely improves your immune protection against this virus. It is only for people who have received the vaccine before and have low antibody levels.
This study tests how safe a Rift Valley fever (RVF) vaccine is and how strongly it triggers the body’s immune response. You may be eligible if you are at risk of RVF exposure and your blood test shows you don’t already have strong protection.
This early-stage trial tests a new dengue vaccine in healthy adults. Participants will receive the vaccine and later be exposed to a weakened dengue virus to see if the vaccine protects them, while being closely monitored for safety and immune response.
This study tests a new experimental vaccine designed to protect against Sudan virus, a rare but serious disease. Researchers will check if the vaccine is safe and helps your immune system fight off the virus.
This trial tests a new vaccine to protect against Marburg virus, a rare but serious infection. The vaccine uses a weakened virus to teach your body to fight the Marburg virus, and researchers are checking if it is safe and how well it works.
This trial tests how the dengue virus affects healthy adults who have never been exposed to dengue or similar viruses. You would be given a controlled dose of the virus and closely monitored to help researchers understand the infection and develop better treatments or vaccines.
Hear when a new Venezuelan Equine Encephalitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.